All articles tagged with #ampa receptors
A recent study has identified increased activity of AMPA receptors and associated inflammation as biological factors behind long COVID brain fog, providing potential targets for future treatments, and confirming the condition as a legitimate clinical issue.
Scientists in Japan have identified increased AMPA receptor activity as a biological cause of Long COVID brain fog, suggesting it is a measurable molecular disorder in the brain and opening avenues for targeted treatments.
Researchers led by Prof. Takuya Takahashi have discovered that increased AMPA receptor density in the brain correlates with cognitive impairment in Long COVID patients, providing a potential biomarker and target for treatment of brain fog associated with the condition.
Scientists have identified increased AMPA receptor levels as a biological basis for Long COVID brain fog, using advanced PET imaging to correlate receptor density with cognitive symptoms and inflammation, paving the way for new diagnostic and treatment options.
A study led by Prof. Takahashi has identified increased AMPA receptor density in the brains of Long COVID patients with cognitive impairment, linking molecular changes to brain fog and suggesting potential targets for diagnosis and treatment.
Scientists have discovered that the brain uses two distinct types of synaptic sites—silenceable and idle-able—to balance learning and stability, allowing new memories to form without erasing old ones. This finding could lead to targeted therapies for neurological disorders and enhance cognitive function.